NCT01234545View on ClinicalTrials.gov

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Interventions
DRUG

activated recombinant human factor VII

Prescription is done at the discretion of the prescribing physician as part of normal clinical routine

Trial Locations (5)

3542

Riyadh

16035

Algiers

20000

Casablanca

Unknown

Muscat

Dubai

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01234545 - Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors | Biotech Hunter | Biotech Hunter